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Abstract mTOR immunoprecipitates contain two 4E-BP1
protein kinase activities. One appears to be due to mTOR itself
and results in the phosphorylation of 4E-BP1 on residues T36 and
T45, as shown previously by others. The other is a kinase which
can be separated from mTOR and which phosphorylates 4E-BP1
within a peptide(s) containing residues S64 and T69. This
phosphorylation, which occurs predominantly on S64, results in
the dissociation of 4E-BP1 from eIF-4E.
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1. Introduction
Insulin plays an important role in the overall regulation of
protein synthesis [1]. In fat cells, insulin increases substantially
the phosphorylation of eIF-4E binding protein-1 (4E-BP1) [2^
6]. In unstimulated cells, the binding of 4E-BP1 to the mRNA
cap-binding protein, eIF-4E, inhibits cap-dependent transla-
tion by blocking the association of eIF-4E with eIF-4G, and
hence the formation of the eIF-4F complex which is necessary
for translational initiation [7^10]. Phosphorylation of 4E-BP1
in response to insulin results in its dissociation from eIF-4E,
allowing the formation of competent eIF-4F complexes
[7,9,11^14].
The phosphorylation of 4E-BP1 in insulin-stimulated fat
cells is complex and appears to occur on at least ¢ve sites
via both rapamycin-sensitive and -insensitive signalling path-
ways [12,15,16]. However, the kinases involved in the phos-
phorylation of this important translational regulator have not
been de¢nitively identi¢ed.
A number of studies have suggested that the mammalian
target of rapamycin (mTOR) plays a key role in the regulation
of protein synthesis (see [17] for review). mTOR is a large
protein (predicted Mr = 289 kDa) containing several structural
motifs including a binding site for the rapamycin-FKBP12
complex (FKBP12, FK506-binding protein of 12 kDa) and
a C-terminal catalytic domain that is homologous to that
found in phosphatidylinositol 3-OH kinases (PI 3-kinases),
although mTOR has not been shown to possess intrinsic lipid
kinase activity [18].
Several recent papers have suggested that 4E-BP1 is phos-
phorylated in vitro by mTOR [19^23]. In this report we con-
¢rm that mTOR immunoprecipitates are able to phosphoryl-
ate a recombinant eIF-4E/4E-BP1 complex. However, we ¢nd
that this phosphorylation is achieved by two separate protein
kinases, one of which appears to be mTOR itself and the
other an mTOR-associated kinase. We have investigated the
e¡ects of these two kinase activities on the dissociation of 4E-
BP1 from the eIF-4E/4E-BP1 complex.
2. Materials and methods
2.1. Materials
Male Wistar rats (160^210 g) were fed ad libitum on a stock labo-
ratory diet (CRM; Bioshore, Manea, Cambs., UK) until the time of
killing. Reagents were as described previously [12] with the following
additions; trypsin was from Boehringer Mannheim; TLC plates (cel-
lulose ¢bre) were from Kodak (Rochester, NY, USA).
2.2. Preparation of rat epididymal fat cell extracts
Isolated rat epididymal fat cells were prepared and incubated as
described previously [12]. Fat cells were extracted in 2.5 ml/g dry
cell weight of ice-cold bu¡er A (50 mM Tris-HCl, pH 8.0, containing
150 mM NaCl, 20 mM NaF, 1 mM EDTA, 1 mM EGTA, 20 mM L-
glycerophosphate, 1 mM DTT, 1 mM PMSF, 1 mM Na3VO4, 1 WM
microcystin-LR and pepstatin, antipain and leupeptin, each at 1 Wg/
ml) by vortex mixing [24].
2.3. Immunoprecipitation of mTOR
Peptides having sequences identical to positions 2433^2450
(DTNAKGNKRSRTRTDSYS) and 1272^1290 (ARRVSKDDW-
LEWLRRLSLE) in mTOR [25] were coupled to keyhole limpet hae-
mocyanin and these conjugates were used to immunise rabbits, as
described previously [26]. The resulting crude sera were designated
Ab 1 and Ab 2, respectively. Fat cell extracts were incubated for 2 h
at 4‡C with 5 mg protein-A Sepharose and anti-mTOR serum at a
dilution of 1:200. The immunoprecipitated material was washed twice
with 50 mM HEPES, pH 7.4, containing 500 mM NaCl, twice with
50 mM HEPES, pH 7.4, containing 150 mM NaCl and once with
assay bu¡er B (10 mM HEPES, pH 7.4, containing 50 mM L-glycer-
ophosphate, 150 mM NaCl, 10 mM MnCl2).
2.4. Measurements of 4E-BP1 kinase activity in mTOR
immunoprecipitates
The immunoprecipitated mTOR pellet was re-suspended in assay
bu¡er B containing microcystin-LR (1 WM), DTT (1 mM) and the
PKA inhibitor, IP20 (200 WM) and incubated for 30 min at 30‡C in a
total volume of 50 Wl with recombinant eIF-4E/4E-BP1 complex or
free 4E-BP1 (equivalent to 0.5 mg/ml 4E-BP1; prepared and puri¢ed
as described [16]), 5 mM MgCl2 and 50 WM [Q-32P]ATP (typically 1000
cpm/pmol). Reactions were stopped by the addition of Laemmli sam-
ple bu¡er and phosphoproteins were separated by SDS-PAGE and
detected by autoradiography with pre-£ashed Amersham Hyper¢lm in
cassettes with intensifying screens.
2.5. Proteolytic digestion, two-dimensional TLC mapping and
phospho-amino acid analysis of 4E-BP1
Radiolabelled 4E-BP1 generated as described above was digested
overnight at 37‡C in 100 mM NEM, pH 8.0, containing 10 Wg trypsin
and then for a further 4 h with an additional 10 Wg trypsin. The
resulting peptides were mapped by TLC with a pH 3.5 bu¡er [pyr-
idine/acetic acid/water (1:10:189, v/v)] for the electrophoresis dimen-
sion and chromatography with pyridine/acetic acid/butanol/water
(10:3:15:12, v/v) bu¡er in the second dimension [27]. The positions
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of radiolabelled peptides were identi¢ed by autoradiography. The
phospho-amino acid content of the radiolabelled 4E-BP1 was deter-
mined as described previously [16].
2.6. Analysis of mTOR protein levels using Western blotting
Samples to be analysed for mTOR levels were run on SDS-PAGE,
transferred to PVDF membrane, blocked with 10% (w/v) milk powder
and probed overnight with a 1:1000 dilution of an antibody raised to
a region of the mTOR protein between amino acids 668 and 939 [28].
After rinsing, the blot was probed with a 1:10,000 dilution of an anti-
rabbit IgG-horse radish peroxidase-linked antibody and the mTOR
band visualised using Amersham ECL Western Blotting detection
reagents.
2.7. Analysis of the dissociation of 4E-BP1 from eIF-4E
Following the phosphorylation of the eIF-4E/4E-BP1 complex by
various kinase fractions as described above, the assay mixture was
tumbled for 90 min at 4‡C with 30 Wl of m7GTP-Sepharose-4B slurry.
The supernatant was removed and the pellet washed with 1 ml bu¡er
B. Proteins present in the supernatant and pellet were separated by
SDS-PAGE and visualised by autoradiography.
3. Results
3.1. Immunoprecipitation of 4E-BP1 kinase activity using
antibodies raised to mTOR
The ability of mTOR immunoprecipitates to phosphorylate
a complex of eIF-4E and the 4E binding protein, BP1, was
assessed using two antibodies raised to di¡erent regions of the
mTOR protein. Extracts of rat epididymal fat cells were im-
munoprecipitated with either Ab 1 or Ab 2 and the resulting
immunoprecipitated material was assayed for its ability to
phosphorylate recombinant 4E-BP1 in a complex with eIF-
4E (Fig. 1a). Of the two antibodies used, only Ab 1 was
able to immunoprecipitate kinase activity towards the eIF-
4E/4E-BP1 complex. This kinase activity appeared to decrease
when the fat cells were treated with insulin, but remained at
control levels when the cells were treated with EGF. No sig-
ni¢cant kinase activity was identi¢ed in Ab 2 immunoprecipi-
tates from either control or insulin-treated extracts (Fig. 1a).
When the amount of mTOR present in these extracts was
assessed by western blotting, it was found that substantially
less mTOR was immunoprecipitated by Ab 1 from insulin-
treated fat cells compared to control extracts, whereas Ab 2
immunoprecipitated equivalent levels of mTOR from control
and insulin-treated cells (Fig. 1b). The lower levels of mTOR
protein in Ab 1 immunoprecipitates from insulin-treated cells
presumably accounts for the decreased phosphorylation of
4E-BP1 seen under these conditions.
To some extent, these data con¢rm the work of Scott et al.
[20], which suggested that an antibody equivalent to Ab 1
immunoprecipitated less mTOR (and hence less 4E-BP1 ki-
nase activity) from insulin-treated 3T3-L1 adipocytes due to
phosphorylation of mTOR within the Ab 1 epitope in re-
sponse to insulin. This phosphorylation appeared to substan-
tially reduce the binding of Ab 1 to mTOR. However, this
group also reported the immunoprecipitation of an insulin-
stimulated 4E-BP1 kinase activity with an antibody raised to
the same region of mTOR as Ab 2. In the present study we
found that Ab 2 did not immunoprecipitate signi¢cant 4E-
BP1 kinase activity, even from insulin treated fat cells,
although mTOR levels in these immunoprecipitates were
equivalent to those in Ab 1 immunoprecipitates from control
cells (Fig. 1b). The reason for this discrepancy is unclear.
To identify the sites within 4E-BP1 which were phospho-
rylated by immunoprecipitates generated using Ab 1, the la-
belled 4E-BP1 was digested with the protease trypsin, and the
resulting peptides subjected to two-dimensional thin layer
analysis (Fig. 2a). The mTOR immunoprecipitates phospho-
rylated 4E-BP1 within two of the three tryptic peptides which
Fig. 1. Immunoprecipitation of 4E-BP1 kinase activity using mTOR
Ab 1 and 2. Rat epididymal fat cells were incubated for 10 min at
37‡C without additions or with the addition of 83 nM insulin or
100 nM EGF prior to extraction in bu¡er A. The fat cell extracts
were then tumbled for 2 h at 4‡C with 5 mg protein-A Sepharose
and a 1:200 dilution of mTOR Ab 1 or 2. The immunoprecipitated
material was washed extensively and divided into two. Half of the
immunoprecipitate was assayed for its ability to phosphorylate re-
combinant eIF-4E/4E-BP1 complex (a) and half was blotted for the
presence of mTOR (b), as described in Section 2. The results are
typical of at least three separate experiments.
Fig. 2. Two-dimensional thin layer analysis of radiolabelled 4E-BP1.
Extracts from control fat cells were immunoprecipitated with
mTOR Ab 1 and the immunoprecipitate used to phosphorylate
eIF4E/4E-BP1 complex. The radiolabelled 4E-BP1 was digested with
trypsin and the resulting peptides separated in two dimensions using
TLC. The position of the radiolabelled peptides was determined us-
ing autoradiography (a). The migration of the two markers, xylene
cyanol (XYL-C) and DNP-lysine (DNP-K), as well as the migration
of the three tryptic peptides from 4E-BP1 which become phospho-
rylated in response to insulin in rat adipocytes is shown in the key
(b). The results are typical of four separate experiments.
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show increased phosphorylation in insulin-stimulated fat cells
in vivo (Fig. 2b). These peptides have been shown previously
to contain the residues S64 and T69 (‘A-peptide’) and T36 and
T45 (‘B-peptide’) [16].
3.2. Isolation of an mTOR-associated 4E-BP1 kinase
The ability of Ab 1 immunoprecipitates to phosphorylate
4E-BP1 was abolished by the presence of detergent (1% NP40)
during the fat cell extraction or washing of the immunopreci-
pitated material (data not shown), in agreement with the work
of Nishiuma et al. [29]. This suggested the possibility that the
phosphorylation of 4E-BP1 by mTOR immunoprecipitates
was due to the presence of an associated kinase which was
released from the immunoprecipitate in the presence of deter-
gent.
In addition, the inability of Ab 2 to immunoprecipitate 4E-
BP1 kinase activity while clearly immunoprecipitating mTOR,
raised the possibility that an mTOR-associated kinase was
responsible, at least in part, for the phosphorylation of 4E-
BP1 seen with Ab 1 immunoprecipitates. Furthermore, it
seemed possible that this kinase could be dissociated from
mTOR by Ab 2. To investigate this hypothesis, fat cell ex-
tracts were immunoprecipitated using Ab 1, and the immuno-
precipitated material was then incubated with Ab 2. Follow-
ing this incubation, 4E-BP1 kinase activity was present in
both the protein A pellet (which contained mTOR) and in
the resulting supernatant (which did not contain signi¢cant
levels of mTOR) (Fig. 3a,b).
The 4E-BP1 kinase activity present in the supernatant could
be further puri¢ed using Mono-Q anion exchange chromatog-
raphy or size exclusion chromatography on Superose 6. The
kinase appeared to have a native molecular weight of approx-
imately 50 kDa and eluted from the Mono-Q column at
350mM NaCl (data not shown).
The sites within 4E-BP1 phosphorylated by mTOR (present
in the protein A pellet) and the mTOR-associated kinase
(present in the supernatant) were investigated as described
for Fig. 2 (Fig. 4a). Two-dimensional thin layer analysis
showed that mTOR phosphorylated 4E-BP1 within tryptic
peptide B (shown to contain mainly phosphothreonine)
whereas the mTOR-associated kinase phosphorylated 4E-
BP1 within tryptic peptide A (shown to contain predomi-
nantly phosphoserine, although a small amount of phospho-
threonine was detected after prolonged autoradiography).
Furthermore, mTOR kinase activity was manganese-depend-
ent and phosphorylated both free 4E-BP1 and 4E-BP1 in a
complex with eIF-4E, whereas the mTOR-associated kinase
was more active in the presence of magnesium and only phos-
phorylated 4E-BP1 when complexed to eIF-4E (Fig. 4b).
3.3. E¡ects of mTOR and the mTOR-associated kinase on the
dissociation of 4E-BP1 from eIF-4E
To investigate the e¡ect of the kinases described in the
present study on the dissociation of 4E-BP1 from eIF-4E,
mTOR immunoprecipitated with Ab 1 was incubated with
Ab 2 and the resulting mTOR pellet and mTOR-associated
kinase were used to phosphorylate the eIF-4E/4E-BP1 com-
plex in the presence of [Q-32P]ATP, as described above. Fol-
lowing incubation with the kinases, the eIF-4E/4E-BP1 com-
plex was precipitated using m7GTP-Sepharose (which binds
eIF-4E and any associated 4E-BP1). Proteins present in the
Fig. 3. E¡ect of mTOR Ab 2 on Ab 1 immunoprecipitates. Extracts
from control fat cells were immunoprecipitated using Ab 1 and the
immunoprecipitates washed as described in Section 2. After wash-
ing, the protein A pellet was incubated for 30 min at 4‡C in 40 Wl
assay bu¡er B with or without a 1:20 dilution of Ab 2. The super-
natant was then removed from the pellet and the pellet was washed
as described above and re-suspended in 40 Wl bu¡er B. Both pellet
(P) and supernatant (S) were then assayed for their ability to phos-
phorylate eIF-4E/4E-BP1 complex (a) and for their mTOR content
(b).
Fig. 4. Phosphorylation of 4E-BP1 by mTOR and the mTOR-asso-
ciated kinase. mTOR and the mTOR-associated kinase were pre-
pared as described for Fig. 3 and used to phosphorylate eIF-4E/4E-
BP1 complex. The radiolabelled 4E-BP1 was digested with trypsin
and the resulting peptides separated by two-dimensional TLC as for
Fig. 2 (a). The phospho-amino acid content of 4E-BP1 which had
been phosphorylated by (1) mTOR or (2) the mTOR-associated ki-
nase is also shown (a). In addition, mTOR and the mTOR-associated
kinase were assayed for their ability to phosphorylate free 4E-BP1
or the eIF-4E/4E-BP1 complex in the presence of MgCl2 (5 mM) or
MnCl2 (5 mM), as described in Section 2 (b). The results are typical
of four separate experiments.
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resulting m7GTP-Sepharose pellet or supernatant were then
separated by SDS-PAGE and the presence of labelled 4E-
BP1 identi¢ed by autoradiography (Fig. 5).
It was found that the phosphorylation of 4E-BP1 by mTOR
did not appear to result in its dissociation from eIF-4E, since
the majority of labelled 4E-BP1 remained in the m7GTP-Se-
pharose pellet. However, phosphorylation of 4E-BP1 by the
mTOR-associated kinase caused almost complete dissociation
from eIF-4E since almost all of the labelled 4E-BP1 was
present in the supernatant following m7GTP-Sepharose treat-
ment. In each case, a proportion (up to 35%) of eIF-4E was
found in the supernatant following m7GTP-Sepharose treat-
ment (data not shown), but since almost all (s 90%) of the
labelled 4E-BP1 was present in the supernatant following
phosphorylation by the mTOR-associated kinase, this is
clearly due to dissociation of 4E-BP1 from eIF-4E rather
than dissociation of the eIF-4E/4E-BP1 complex from the
m7GTP-Sepharose pellet.
4. Discussion
Experiments in our laboratory and others have shown that
in primary rat adipocytes, 4E-BP1 is phosphorylated in re-
sponse to insulin on ¢ve sites which lie within three separate
tryptic peptides [15,16]. Four of these sites, S64 and T69 (with-
in tryptic peptide A) and T36 and T45 (within tryptic peptide
B), ¢t a Ser/Thr-Pro motif and are phosphorylated via a ra-
pamycin-sensitive signalling pathway. The ¢nal site, S111
(within tryptic peptide C) does not appear to be a proline-
directed site, and is phosphorylated via a rapamycin-insensi-
tive signalling pathway [16].
In the present study we identi¢ed two separate kinase ac-
tivities which were both immunoprecipitated by an antibody
raised to a C-terminal region of mTOR (Ab 1). The Ab 1
immunoprecipitate contained kinase activities which phos-
phorylated the eIF-4E/4E-BP1 complex within tryptic pepti-
des A and B (Fig. 2). At the present time the e¡ect of insulin
on these kinase activities remains unresolved, since this hor-
mone appears to substantially decrease the binding of mTOR
(and presumably mTOR-associated proteins) to Ab 1 (Fig. 1).
A second antibody raised to a more central region of
mTOR (Ab 2) appeared unable to immunoprecipitate signi¢-
cant kinase activity towards the eIF-4E/4E-BP1 complex. This
raised the possibility that the phosphorylation of 4E-BP1 by
Ab1 immunoprecipitates might be due, at least in part, to the
presence of an mTOR-associated kinase, rather than mTOR
itself. This hypothesis was also supported by the ¢nding of
our group and others [29], that the presence of detergent with-
in the immunoprecipitate abolished the 4E-BP1 kinase activ-
ity.
With this in mind, an attempt to isolate the mTOR-associ-
ated kinase was undertaken. Crucially, it was found that the
addition of Ab 2 to Ab 1 immunoprecipitates resulted in the
release of a 4E-BP1 kinase activity into the supernatant, while
mTOR itself remained in the protein A pellet. Thus two sep-
arable kinase activities were identi¢ed. The ¢rst remained in
the protein A pellet, was manganese-dependent and was more
active towards free 4E-BP1 rather than 4E-BP1 in a complex
with eIF-4E (3.8 þ 1.8-fold, for three separate experiments).
This kinase phosphorylated 4E-BP1 within tryptic peptide B
(previously shown to contain residues T36 and T45 [16]). It is
highly likely that this kinase activity represents mTOR itself,
and the ability of this kinase to phosphorylate residues T36
and T45 is in agreement with a number of recent studies [21^
23]. However, we cannot exclude the possibility that the phos-
phorylation of 4E-BP1 by the mTOR-containing pellet is due
to another kinase which remains tightly associated with
mTOR, even during the procedures employed in the present
study.
The second kinase was released into the supernatant upon
treatment with Ab 2 and was therefore free of mTOR. This
kinase was speci¢c for 4E-BP1 in a complex with eIF-4E, was
more active in the presence of magnesium (although it was
able to use manganese alone) and phosphorylated 4E-BP1
within tryptic peptide A (previously shown to contain residues
S64 and T69 [16]). Phosphorylation by this mTOR-associated
kinase appeared to occur predominantly on serine residues,
suggesting that the major site phosphorylated was S64 (Fig.
4a). Consistent with this conclusion, we found that the kinase
was able to phosphorylate a synthetic peptide containing res-
idues S64 and T69 (data not shown).
When the e¡ects of these kinases on the eIF-4E/4E-BP1
complex were investigated, it was found that phosphorylation
of 4E-BP1 in a complex with eIF-4E by the mTOR-associated
kinase caused dissociation of 4E-BP1 from eIF-4E, whereas
phosphorylation of the complex by the mTOR-containing pel-
let was without e¡ect.
This conclusion supports that of Gingras et al. who re-
ported recently that the phosphorylation of 4E-BP1 in the
eIF-4E/4E-BP1 complex by mTOR at residues T36 and T45
did not result in the dissociation of 4E-BP1 from eIF-4E
[22]. Two other groups have also claimed that mTOR immu-
noprecipitates phosphorylate 4E-BP1 at residues T36 and T45
[21,23], but state that phosphorylation at these residues pre-
vented the association of phosphorylated 4E-BP1 with eIF-
4E. However, these in vitro studies did not focus directly on
the e¡ect of phosphorylation of 4E-BP1 on its dissociation
from the eIF-4E/4E-BP1 complex. It should be noted that
while phosphorylation of T36 and T45 may be enough to pre-
vent the association of 4E-BP1 with eIF-4E, it may not be
su⁄cient to cause dissociation of 4E-BP1 from the eIF-4E/4E-
BP1 complex. Burnett et al. have reported that mutants of T36
and T45 expressed in HEK 293 cells bind constitutively to eIF-
4E and hence argue that phosphorylation of these residues in
vivo causes the dissociation of 4E-BP1 from eIF-4E [21].
However, Gingras et al. claim that phosphorylation of these
residues, although not responsible for dissociation itself, is a
Fig. 5. E¡ect of mTOR and the mTOR-associated kinase on the
dissociation of 4E-BP1 from eIF-4E. mTOR and the mTOR-associ-
ated kinase were used to phosphorylate the eIF-4E/4E-BP1 complex
as described for Fig. 3. Following incubation for 30 min at 30‡C,
the kinase assay mixture was tumbled for 90 min at 4‡C with
m7GTP-Sepharose slurry, as described in Section 2. The supernatant
(S) was then removed and the m7GTP-Sepharose pellet (P) was
washed with 1 ml bu¡er B and then resuspended in 30 Wl bu¡er B.
Proteins present in the pellet and supernatant were separated by
SDS-PAGE and the location of labelled 4E-BP1 determined by ra-
dioautography. The results are typical of six separate experiments.
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prerequisite for phosphorylation of the other sites in 4E-BP1
[22] and so mutating T36 and T45 would prevent the phos-
phorylation of the sites needed to cause dissociation.
Our results show that phosphorylation of 4E-BP1 by
mTOR does not result in dissociation of the eIF-4E/4E-BP1
complex. However, phosphorylation by mTOR at residues T36
and T45 in our study does not appear to be a prerequisite for
phosphorylation of the other sites in 4E-BP1, since the
mTOR-associated kinase is able to phosphorylate 4E-BP1 in
the absence of mTOR. Furthermore, phosphorylation of 4E-
BP1 by this mTOR-associated kinase is su⁄cient to cause
dissociation from eIF-4E. This phosphorylation appears to
occur predominantly at residue S64. Early studies also sug-
gested that phosphorylation of 4E-BP1 on residue S64 resulted
in dissociation of the eIF-4E/4E-BP1 complex [30]. More re-
cently, Fadden et al. have shown that phosphorylation of a
form of 4E-BP1 mutated at S64 by MAP kinase prevented its
association with eIF-4E, implying that phosphorylation of S64
was not involved in dissociation of the eIF-4E/4E-BP1 com-
plex [15]. Again, this work did not directly examine dissocia-
tion. Thus it is possible that phosphorylation of residues other
than S64 may prevent the association of 4E-BP1 with eIF-4E
without actually causing the dissociation of 4E-BP1 from the
eIF-4E/4E-BP1 complex.
In conclusion, we have now identi¢ed three kinases which
phosphorylate 4E-BP1 within the three tryptic peptides which
show an increase in phosphorylation in response to insulin.
Our previous studies identi¢ed an insulin-stimulated kinase
from rat adipocytes which phosphorylated 4E-BP1 at S111
via a rapamycin-insensitive signalling pathway [16]. The
present study has con¢rmed that mTOR (or a tightly associ-
ated kinase) phosphorylates 4E-BP1 at T36 and/or T45 and has
identi¢ed an mTOR-associated kinase which phosphorylates
4E-BP1 within a peptide containing residues S64 and T69. The
e¡ect of insulin on the activities of mTOR and the mTOR-
associated kinase is currently under investigation. Of these
three kinases, only the mTOR-associated kinase (which ap-
pears to predominantly phosphorylate 4E-BP1 at residue
S64) causes the dissociation of 4E-BP1 from the eIF-4E/4E-
BP1 complex. All three kinases appear to be able to act sep-
arately to phosphorylate 4E-BP1 in vitro, and further studies
are needed to elucidate the order and importance of the in-
dividual phosphorylation events and the signi¢cance of a po-
tential mTOR/4E-BP1 kinase complex in vivo.
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